Building conviction on $BOMP and $VIBECODOOR for the mid to long-term play. These two are on my radar as solid positions to hold through the current market cycle. Looking to see how they perform as the market evolves. Not rushing, just patient capital allocation here.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
10 Likes
Reward
10
7
Repost
Share
Comment
0/400
BearHugger
· 01-07 22:53
Sounds stable, but recently there hasn't been much movement on $BOMP, so we'll have to see if it can really take off later.
View OriginalReply0
RealYieldWizard
· 01-05 23:37
Be patient and hold these two assets; it really depends on how they perform in the future.
View OriginalReply0
ShitcoinConnoisseur
· 01-05 21:03
Haha, it's the same old story... Just wait and see how they perform. Anyway, I'm also watching these two, but it depends on how things develop later.
View OriginalReply0
CryptoCross-TalkClub
· 01-05 21:03
Laughing out loud, it's that phrase "patient capital allocation" again. Next month, I'll hear your story about cutting losses.
View OriginalReply0
LightningSentry
· 01-05 20:56
bomp and vibecodoor are both paying attention. These two do have some potential. Long-term holdings, not rushing to sell. Just waiting to see how things develop later.
View OriginalReply0
DeFiCaffeinator
· 01-05 20:54
bomp is quite interesting, I haven't heard of vibecodoor, still doing research... Can these two really last until the next cycle?
View OriginalReply0
NonFungibleDegen
· 01-05 20:37
ngl ser, patient capital allocation is just cope for "i got apedheavy and now i'm bagholding" but also... respect the conviction play. floor prices tho? probably nothing lol
Building conviction on $BOMP and $VIBECODOOR for the mid to long-term play. These two are on my radar as solid positions to hold through the current market cycle. Looking to see how they perform as the market evolves. Not rushing, just patient capital allocation here.